Form 4: BioLife Solutions CFO Troy Wichterman Reports Stock Grants

Troy Wichterman, CFO of BioLife Solutions, reports the acquisition of common stock through restricted stock grants as part of the company's incentive plans.

Summary

• On March 18, 2025, Troy Wichterman, the Chief Financial Officer of BioLife Solutions Inc., reported the acquisition of 38,102 shares of common stock.
• These shares were granted as restricted stock under the BioLife Solutions 2023 Omnibus Performance Incentive Plan and will vest 25% on the first anniversary of the grant date, followed by quarterly installments over the next 12 quarters.
• Additionally, Wichterman acquired 60,018 shares of common stock granted pursuant to the 2013 Performance Incentive Plan.
• These shares vested at 175% of the reported number based on the company's total shareholder return from January 1, 2023, to December 31, 2024, compared to its peers.
• Following these transactions, Wichterman directly owns 214,929 shares of BioLife Solutions Inc. common stock.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, indicating a stable and incentivized management structure. This is generally viewed positively.

Positives

• The grants of restricted stock align the CFO's interests with those of the shareholders.
• The vesting schedule of the 2023 plan encourages long-term commitment from the CFO.
• The performance-based vesting of the 2013 plan incentivizes the CFO to drive shareholder value.

Industry Context

Stock grants to executives are a common practice in the biotechnology industry to incentivize performance and align management's interests with those of shareholders.

Comparison to Industry Standards

• Stock grants are a typical component of executive compensation packages in the biotech industry.
• Companies like Thermo Fisher Scientific and Danaher also utilize stock-based compensation to incentivize their executives.
• The vesting schedules and performance metrics used by BioLife Solutions are generally in line with industry practices.

Stakeholder Impact

• The stock grants align management's interests with shareholders, potentially leading to increased shareholder value.
• Employees may be motivated by the company's commitment to performance-based compensation.

Key Dates

Keywords

BioLife Solutions, BLFS, Troy Wichterman, CFO, Form 4, Stock Grant, Restricted Stock, Shareholder Return, Beneficial Ownership, Incentive Plan